About Srivar Pharma Private Limited
Data last updated:
Srivar Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2009PTC064986. Its GSTIN is 36AACCE2347K1ZM (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. It was formerly known as Dsr Labs Private Limited and Eva Drugs Private Limited. It is led by directors Sishtla Ramakrishnan (Managing Director) and Sistla Prabhavathi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy.No – 104 Rtc Colony Lal Bazar Secunderabad, Hyderabad, Telangana, India – 500011.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.53 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.14 Lakh (net margin 4%) and EBITDA of ₹1.02 Cr (EBITDA margin 40.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 14% over five years.
The company has about 20 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Srivar Pharma. As per MCA filings, the company has open charges of ₹8.58 Cr and satisfied charges of ₹5 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹5.9 Cr; the latest was in June 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Nexus Drugs Private Limited with revenue of ₹2.54 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srivarpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSy.No – 104 Rtc Colony Lal Bazar Secunderabad, Hyderabad, Telangana, India – 500011
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Srivar Pharma Private Limited
The main business activity of Srivar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Srivar Pharma Private Limited FY 2024 filings available
Srivar Pharma Private Limited reported revenue of ₹2.53 Cr (up 1250% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Srivar Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years. EBITDA rose 131% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Srivar Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.02 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.14 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Srivar Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Srivar Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Srivar Pharma Private Limited
Srivar Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexus Drugs Private Limited | ₹2.54 Cr (FY 2024) | •••• | •••• | -60.0% | •••• | Hyderabad, Telangana, India |
| Xiolife Pharmaceuticals and Healthcare Private Limited | ₹2.53 Cr (FY 2025) | •••• | •••• | 82.0% | •••• | Guwahati, Assam, India |
| Biomics Pharmaceuticals Private Limited | ₹2.53 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Karur, Tamil Nadu, India |
| Medchl Chemicals and Pharmaceuticals Pvt.Ltd. | ₹2.53 Cr (FY 2016) | •••• | •••• | -37.0% | •••• | Secunderabad, Telangana, India |
| Sabme Pharmaceuticals Private Limited | ₹2.53 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Jamshedpur, Jharkhand, India |
| Srivar Pharma Private Limited this company | ₹2.53 Cr (FY 2024) | •••• | •••• | 1250.0% | •••• | Hyderabad, Telangana, India |
| Signa Pharma Private Limited | ₹2.53 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Uttar Pradesh, India |
| Aislin Formulations Private Limited | ₹2.53 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Delhi, India |
| Pranjivani Wellness Private Limited | ₹2.52 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Gurgaon, Haryana, India |
| Polymed Pharmaceuticals Private Limited | ₹2.52 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Jalgaon, Maharashtra, India |
| Octalife Pharma Private Limited | ₹2.51 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Vadodara, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Srivar Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Srivar Pharma Private Limited
Srivar Pharma Private Limited is audited by VIJAY NARAYAN & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIJAY NARAYAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Srivar Pharma Private Limited
Srivar Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sishtla Ramakrishnan Also directs: Avidia Pharma Labs LLP, Aalto Biotech Private Limited, Shreegen Pharma Limited and 2 more | Managing Director | 05 Oct 2017 | 9 Years 0 Months | Current |
| Sistla Prabhavathi | Whole-Time Director | 05 Oct 2017 | 9 Years 0 Months | Current |
Ownership and Shareholding of Srivar Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Srivar Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2022 | Others | ₹58 Lakh | Open |
| 15 Mar 2022 | Others | ₹8 Cr | Open |
| 20 Jul 2015 | Andhra Pradesh State Financial Corporation | ₹1.61 Cr | Satisfied |
| 27 Jun 2013 | Andhra Pradesh State Financial Corporation | ₹3.39 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Srivar Pharma Private Limited
Srivar Pharma Private Limited has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹5.9 Cr; the latest was in June 2018.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2017 | Funding round | ₹4.45 Cr | Investors: an individual |
| Oct 2016 | Funding round | ₹1.45 Cr | Investors: an individual |
| Apr 2015 | Rights issue | ₹2.11 Cr | Investors: 4 individuals |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Srivar Pharma Private Limited
Srivar Pharma Private Limited has 6 court cases on record: 1 filed by Srivar Pharma, 1 filed against it, 4 where it is another party. 1 case is pending and 5 are disposed. Status as checked between 21 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chittoor, Andhra Pradesh | Criminal complaint | Filed against the company by Food Safety and Standards Authority of India | Pending |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against A-1 M/S. Celtiss Theraputics Pvt. Ltd | Disposed |
| High Court for State of Telangana | Writ petition | Company is another party | Disposed |
| High Court of Andhra Pradesh | Writ petition | Company is another party | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Srivar Pharma Private Limited
Srivar Pharma operates one associated brand: Srivar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceuticals, nutraceuticals, and wellness products in India. | srivarpharma.com |
Employees and EPFO Compliance at Srivar Pharma Private Limited
Srivar Pharma Private Limited has a workforce of 20 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Srivar Pharma Private Limited
Srivar Pharma has undergone 2 name changes throughout its history. The company was previously known as Dsr Labs Private Limited, and Eva Drugs Private Limited. The current legal name is Srivar Pharma Private Limited.
| Company Name | Status |
|---|---|
| Srivar Pharma Private Limited | Current |
| Dsr Labs Private Limited | Previous |
| Eva Drugs Private Limited | Previous |
CIN History of Srivar Pharma Private Limited
Srivar Pharma has one previous CIN (Corporate Identification Number): U24100AP2009PTC064986. The current CIN is U24100TG2009PTC064986, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2009PTC064986 | Current |
| U24100AP2009PTC064986 | Previous |
Recent Activity on Srivar Pharma Private Limited
Srivar Pharma Private Limited has 16 board changes on record since 2009: 9 appointments and 7 cessations. The latest: Ramanaiah Madupaduga ceased to be Additional Director on 20 Aug 2024.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Srivar Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Srivar Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Srivar Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Srivar Pharma Private Limited
Srivar Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCE2347K1ZM | Telangana | Active | 21 Nov 2019 |
| 37AACCE2347K1ZK | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Srivar Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srivar Pharma Private Limited
Srivar Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 September 2009 (17+ years old) and is registered under CIN U24100TG2009PTC064986.
Srivar Pharma reported revenue of ₹2.53 Cr for FY 2024 (up 1250% YoY).
Srivar Pharma has 2 current directors:
- Sishtla Ramakrishnan - Managing Director
- Sistla Prabhavathi - Whole-Time Director
Srivar Pharma reported a net profit of ₹10.14 Lakh (net margin 4%) and EBITDA of ₹1.02 Cr (EBITDA margin 40.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Srivar Pharma is -20% over three years and 14% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Srivar Pharma is 36AACCE2347K1ZM, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCE2347K1ZK (Andhra Pradesh).
The CIN (Corporate Identification Number) of Srivar Pharma is U24100TG2009PTC064986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srivar Pharma has 6 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Srivar Pharma was incorporated on 09 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srivar Pharma has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹5.9 Cr; the latest was in June 2018.
The peers of Srivar Pharma by revenue are Nexus Drugs Private Limited, Xiolife Pharmaceuticals and Healthcare Private Limited, Biomics Pharmaceuticals Private Limited, Medchl Chemicals and Pharmaceuticals Pvt.Ltd, Sabme Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).